In COVID-19, a peculiar phenotype was observed in critical disease, consisting of a highly impaired IFN type I response (characterized by no IFNβ and low IFNα production and activity) and a low ISG signature in peripheral blood, which was associated with a persistent blood viral load and an exacerbated inflammatory response [80]. This evidence concerns the gene IFNA2 and COVID-19.